H. Maagdenberg

Characteristics and quality of oral anticoagulation treatment in pediatric patients in the Netherlands based on the CAPS cohort

A. de Boer, A. H. Maitland‐van der Zee, F. V. D. van der Meer, 2018, Journal of thrombosis and haemostasis : JTH.

REMOVAL OF RADIOACTIVE STRONTIUM AND CESIUM FROM VEGETABLES AND FRUITS DURING PREPARATION FOR PRESERVATION

J. W. Ralls, H. Maagdenberg, T. R. Guckeen, 1971 .

ALTERNATE STORAGE SYSTEMS FOR THE PRODUCTION OF CANNED BLACK RIPE OLIVES

H. Maagdenberg, W. A. Mercer, Jack W. Raus, 1971 .

Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine

B. Carleton, A. de Boer, A. H. Maitland‐van der Zee, 2016, Pediatric Drugs.

Effects of age and genetic variations in VKORC1, CYP2C9 and CYP3A4 on the phenprocoumon dose in pediatric patients.

S. Cessie, J. Swen, A. H. Maitland‐van der Zee, 2018, Pharmacogenomics (London).

The pediatric acenocoumarol dosing algorithm: the Children Anticoagulation and Pharmacogenetics Study

S. Cessie, J. Swen, A. H. Maitland‐van der Zee, 2018, Journal of thrombosis and haemostasis : JTH.

Genetic variants associated with methotrexate-induced mucositis in cancer treatment: a systematic review and meta-analysis.

B. Carleton, E. Lopez-Lopez, D. Gemmati, 2021, Critical reviews in oncology/hematology.

IN-PLANT, CONTINUOUS HOT-GAS BLANCHING OF SPINACH

D. Homnick, J. W. Ralls, H. Maagdenberg, 1973 .